These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Can prion-like propagation occur in neurodegenerative diseases?: in view of transmissible systemic amyloidosis]. Yoshida K; Higuchi K; Ikeda S Brain Nerve; 2012 Jun; 64(6):665-74. PubMed ID: 22647474 [TBL] [Abstract][Full Text] [Related]
3. Amyloids, prions and the inherent infectious nature of misfolded protein aggregates. Soto C; Estrada L; Castilla J Trends Biochem Sci; 2006 Mar; 31(3):150-5. PubMed ID: 16473510 [TBL] [Abstract][Full Text] [Related]
4. The cell biology of prion-like spread of protein aggregates: mechanisms and implication in neurodegeneration. Costanzo M; Zurzolo C Biochem J; 2013 May; 452(1):1-17. PubMed ID: 23614720 [TBL] [Abstract][Full Text] [Related]
5. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers. Ugalde CL; Finkelstein DI; Lawson VA; Hill AF J Neurochem; 2016 Oct; 139(2):162-180. PubMed ID: 27529376 [TBL] [Abstract][Full Text] [Related]
6. The allure and pitfalls of the prion-like aggregation in neurodegeneration. Ezzat K; Espay AJ Handb Clin Neurol; 2023; 193():17-22. PubMed ID: 36803809 [TBL] [Abstract][Full Text] [Related]
7. Prions: a model of conformational disease? Morinet F Pathol Biol (Paris); 2014 Apr; 62(2):96-9. PubMed ID: 24656441 [TBL] [Abstract][Full Text] [Related]
9. Generalization of the prion hypothesis to other neurodegenerative diseases: an imperfect fit. Guest WC; Silverman JM; Pokrishevsky E; O'Neill MA; Grad LI; Cashman NR J Toxicol Environ Health A; 2011; 74(22-24):1433-59. PubMed ID: 22043906 [TBL] [Abstract][Full Text] [Related]
10. Application of yeast to studying amyloid and prion diseases. Chernoff YO; Grizel AV; Rubel AA; Zelinsky AA; Chandramowlishwaran P; Chernova TA Adv Genet; 2020; 105():293-380. PubMed ID: 32560789 [TBL] [Abstract][Full Text] [Related]
11. Cross-seeding of prions by aggregated α-synuclein leads to transmissible spongiform encephalopathy. Katorcha E; Makarava N; Lee YJ; Lindberg I; Monteiro MJ; Kovacs GG; Baskakov IV PLoS Pathog; 2017 Aug; 13(8):e1006563. PubMed ID: 28797122 [TBL] [Abstract][Full Text] [Related]
12. Amyloid and prions: some biochemical investigations of cerebral amyloidosis in mice. Hope J; Kirby L Folia Neuropathol; 2012; 50(1):13-9. PubMed ID: 22505360 [TBL] [Abstract][Full Text] [Related]
13. Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins. Meredith SC Ann N Y Acad Sci; 2005 Dec; 1066():181-221. PubMed ID: 16533927 [TBL] [Abstract][Full Text] [Related]
14. The transcellular spread of cytosolic amyloids, prions, and prionoids. Aguzzi A; Rajendran L Neuron; 2009 Dec; 64(6):783-90. PubMed ID: 20064386 [TBL] [Abstract][Full Text] [Related]
15. Misfolded protein aggregates: mechanisms, structures and potential for disease transmission. Moreno-Gonzalez I; Soto C Semin Cell Dev Biol; 2011 Jul; 22(5):482-7. PubMed ID: 21571086 [TBL] [Abstract][Full Text] [Related]
16. Prion-like aggregates: infectious agents in human disease. Westermark GT; Westermark P Trends Mol Med; 2010 Nov; 16(11):501-7. PubMed ID: 20870462 [TBL] [Abstract][Full Text] [Related]
17. Cell Biology of Prions and Prionoids: A Status Report. Aguzzi A; Lakkaraju AKK Trends Cell Biol; 2016 Jan; 26(1):40-51. PubMed ID: 26455408 [TBL] [Abstract][Full Text] [Related]
18. Harnessing the power of yeast to unravel the molecular basis of neurodegeneration. Tenreiro S; Munder MC; Alberti S; Outeiro TF J Neurochem; 2013 Nov; 127(4):438-52. PubMed ID: 23600759 [TBL] [Abstract][Full Text] [Related]
19. Quantifying the sequence-dependent species barrier between hamster and mouse prions. Lee LY; Chen RP J Am Chem Soc; 2007 Feb; 129(6):1644-52. PubMed ID: 17243682 [TBL] [Abstract][Full Text] [Related]